Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
190
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
+2.23M
-
Total reported value, excl. options
-
$2.24B
-
Value change
-
+$101M
-
Put/Call ratio
-
0.08
-
Number of buys
-
137
-
Number of sells
-
-55
-
Price
-
$44.29
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2022
219 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q3 2022.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 190 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
of 57.1M outstanding shares and own 88.28% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), FMR LLC (5.62M shares), BlackRock Inc. (4.8M shares), Vivo Capital, LLC (3.4M shares), VANGUARD GROUP INC (3M shares), JANUS HENDERSON GROUP PLC (1.52M shares), Invesco Ltd. (1.17M shares), venBio Partners LLC (1.13M shares), STATE STREET CORP (1.08M shares), and AMERICAN CENTURY COMPANIES INC (714K shares).
This table shows the top 190 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.